
A vascular surgeon spent years making high-stakes decisions one patient at a time. Now he is building Doctronic around a harder question: how much good judgment can software deliver when the waiting room has no walls?
Nicolas Abad is the co-founder and CEO of Telepatia, a Latin American healthtech company building AI healthcare workers - starting with an 'AI Doctor' that transcribes consultations, reviews records, flags drug interactions, and surfaces clinical guidance in real time. Named after his late father's nickname, the company grew from a Stanford MBA side obsession to a venture backed by Andreessen Horowitz, reaching more than 14 million patients across five countries inside its first year. Abad's stated ambition is audacious to the point of comedy: win Latin America's first Nobel Prize in Medicine since 1984 by turning healthcare from scarcity into abundance.